Table 2.
Comparison between PDAC and control groups regarding HOXA9 staining
| PDAC | Control | Test of Sig. | p | |
|---|---|---|---|---|
| H-score | ||||
| Min. – Max. | 20–300 | 0–210 |
Z = 8.459* |
< 0.001* |
| Mean ± SD. | 180.9 ± 79.1 | 44.29 ± 46.79 | ||
| Median (IQR) | 180 (100–270) | 30 (0–80) | ||
| Intensity | ||||
| Negative | 0 (0%) | 38 (38.8%) |
MH = 133.500* |
< 0.001* |
| Mild | 13 (13.3%) | 45 (45.9%) | ||
| Moderate | 39 (39.8%) | 14 (14.3%) | ||
| Strong | 46 (46.9%) | 1 (1%) | ||
| Percentage | ||||
| Min. – Max. | 20–100 | 0–90 |
Z = 7.695* |
< 0.001* |
| Mean ± SD. | 74.80 ± 18.29 | 34.5 ± 32.2 | ||
| Median (IQR) | 80 (60–90) | 30 (0–60) | ||
SD: Standard deviation Z: Wilcoxon signed ranks test
MH: Marginal Homogeneity Test
p: p value for comparing between tumor and control
*: Statistically significant at p ≤ 0.05